AnGes MG, Osaka University, Aoki Undertake Co-development of Fully Bioabsorbable Stent.
In this project, the three partners will strive to develop a stent made of magnesium alloy. The new stent may help prevent the development of restenosis. Specifically, Osaka University will be responsible for animal experiments to evaluate the magnesium stent, Aoki will examine the magnesium processing technology, and AnGes MG will design the form of stent while considering conditions for NF-kappa B decoy oligodeoxynucleotide coating.
Adopted by the Ministry of Economy, Trade and Industry as one of Consortium R&D projects for regional revitalization, this project will receive a subsidiary for next 2 years. Bio-Sight Capital supervises the entire project while the three partners are proceeding with research.
Source: JCN http://www.japancorp.net
Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
|Printer friendly Cite/link Email Feedback|
|Publication:||JCNN News Summaries|
|Date:||Oct 15, 2005|
|Previous Article:||Sanofi-aventis Japan Acquires Production and Sales Rights of Ancaron Antiarrhythmic Agent from Taisho Pharmaceutical.|
|Next Article:||Mochida Pharmaceutical Adopts British Inpharmatica's In-silico ADME Suite, Admensa Interactive.|